Yes I think McRae has gone.
AHZ has to break now.
Look at what they have compared to other biotechs like NEU & PBT. I actually own some PBT.
Actually I shouldnt refer to them as a biotech. They are a diverse healthcare company.
They have medical product sales whose sales are steadily growing.
They have a shot at a huge leap in revenue vie Cardiocel. HUGE.
Then they have the biotech side with MONSTER potential $6B p.a (market size)potential. This product has great science behind it, and a very experienced and succesful scientist running it.
It seems inevitable to me that this will gap up very soon.
thoughts _overhang gone?, page-38
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $215.6M | |||
| Open | High | Low | Value | Volume |
| $10.73 | $10.73 | $10.15 | $109.7K | 10.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 490 | $10.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $10.20 | 911 | 1 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| AVR (ASX) Chart |